CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 6.69
+0.04 (0.60%)
Jun 26, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, CSPC Pharmaceutical Group stock has a consensus rating of "Buy" and an average price target of $11.57. The average 1-year stock price forecast is 72.94% higher than the current stock price, while the lowest is $6.00 (-10.31%) and the highest is $19.36 (+189.39%).
Price Target: $11.57 (+72.94%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CSPC Pharmaceutical Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 19 | 17 | 15 | 15 | 15 | 15 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 6 | 5 | 5 | 5 | 3 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 3 | 3 |
| Total | 30 | 27 | 25 | 25 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $18.00 | Buy | Maintains | $18.00 | +169.06% | Jun 3, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Hold Maintains $8.05 | Hold | Maintains | $8.05 | +20.33% | Jun 2, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $10.90 | Buy | Maintains | $10.90 | +62.93% | Jun 1, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $19.36 | Buy | Maintains | $19.36 | +189.39% | May 30, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $12.00 | Buy | Maintains | $12.00 | +79.37% | May 29, 2026 |
Financial Forecast
Revenue This Year
31.32B
from 26.01B
Increased by 20.42%
Revenue Next Year
30.94B
from 31.32B
Decreased by -1.20%
EPS This Year
0.61
from 0.31
Increased by 96.54%
EPS Next Year
0.63
from 0.61
Increased by 4.46%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 37.5B | ||
| Avg | 31.3B | ||
| Low | 27.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 44.2% | ||
| Avg | 20.4% | ||
| Low | 6.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.94 | ||
| Avg | 0.61 | ||
| Low | 0.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 203.3% | ||
| Avg | 96.5% | ||
| Low | 6.8% |